With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica

12th October 2017 Uncategorised 0

Bracing for impending competition to its big-selling Lyrica, Pfizer has won FDA approval for a longer-lasting version that could help it defend sales against cheap generics.

More: With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
Source: fierce